Multi-composite bioactive osteogenic sponges featuring mesenchymal stem cells, platelet-rich plasma, nanoporous silicon enclosures, and peptide amphiphiles for rapid bone regeneration

Journal of Functional Biomaterials

Volumn 2, Issue 2, 2011, Pages 39-66

  Murphy, Matthew B ^a   Blashki, Daniel ^b   Buchanan, Rachel M ^a,c   Fan, Dongmei ^a   De Rosa, Enrica ^a   Shah, Ramille N ^d   Stupp, Samuel I ^d   Weiner, Bradley K ^e   Simmons, Paul J ^b   Ferrari, Mauro ^a   Tasciotti, Ennio ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c The University of Texas at Austin   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Bone regeneration; Composite scaffold; Mesenchymal stem cells; Nanoporous silicon; Peptide amphiphiles; Platelet rich plasma; Tissue engineering

Indexed keywords

AMPHOPHILE; BONE MORPHOGENETIC PROTEIN 2; MULTI COMPOSITE BIOACTIVE OSTEOGENIC SPONGE; NANOCOMPOSITE; SILICON; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMICAL COMPOSITION; CONTROLLED STUDY; IN VITRO STUDY; MALE; MATERIAL COATING; MESENCHYMAL STEM CELL; MINERALIZATION; NONHUMAN; PROTEIN SECRETION; RAT; REGENERATIVE ABILITY; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

EID: 85065220427     PISSN: None     EISSN: 20794983     Source Type: Journal    
DOI: 10.3390/jfb2020039     Document Type: Article

References (103)

1. Goldstein, S.A.; Bonadio, J. Potential role for direct gene transfer in the enhancement of fracture healing. Clin Orthop Relat Res. 1998, 355, S154-S162.
2. MDI, U.S. Markets for Biomaterials; Medical Data International, Inc.: Santa Ana, CA, USA, 2000.
3. Yaszemski, M.J.; Payne, R.G.; Hayes, W.C.; Langer, R.; Mikos, A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996, 17, 175-185.
4. Freed, L.E.; VunjakNovakovic, G. Tissue engineering bioreactors. In Principles of Tissue Engineering; Academic Press: San Diego, CA, USA, 2000; pp. 143-156.
5. Garcia, A.J.; Ducheyne, P.; Boettiger, D. Effect of surface reaction stage on fibronectin-mediated adhesion of osteoblast-like cells to bioactive glass. J. Biomed. Mater. Res. 1998, 40, 48-56.
6. Holy, C.E.; Shoichet, M.S.; Davies, J.E. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period. J. Biomed. Mater. Res. 2000, 51, 376-382.
7. Ishaug, S.L.; Crane, G.M.; Miller, M.J.; Yasko, A.W.; Yaszemski, M.J.; Mikos, A.G. Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J. Biomed. Mater. Res. 1997, 36, 17-28.
8. Ma, P.X.; Zhang, R.Y.; Xiao, G.Z.; Franceschi, R. Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J. Biomed. Mater. Res. 2001, 54, 284-293.
9. Marra, K.G.; Szem, J.W.; Kumta, P.N.; DiMilla, P.A.; Weiss, L.E. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J. Biomed. Mater. Res. 1999, 47, 324-335.
10. Schoeters, G.; Leppens, H.; Van Gorp, U.; Van Den Heuvel, R. Haemopoietic long-term bone marrow cultures from adult mice show osteogenic capacity in vitro on 3-dimensional collagen sponges. Cell Proliferation 1992, 25, 587-603.
11. Xynos, I.D.; Hukkanen, M.V.; Batten, J.J.; Buttery, L.D.; Hench, L.L.; Polak, J.M. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: Implications and applications for bone tissue engineering. Calcif. Tissue Int. 2000, 67, 321-329.
12. Crane, G.M.; Ishaug, S.L.; Mikos, A.G. Bone tissue engineering. Nat. Med. 1995, 1, 1322-1324.
13. Murphy, M.B.; Blashki, D.; Buchanan, R.M.; Tasciotti, E. Engineering a better way to heal broken bones. Chem. Eng. Prog. 2010, 106, 37-43.
14. Nimni, M.E.; Cheung, D.; Strates, B.; Kodama, M.; Sheikh, K. Chemically modified collagen: A natural biomaterial for tissue replacement. J. Biomed. Mater. Res. 1987, 21, 741-771.
15. Kale, S.; Biermann, S.; Edwards, C.; Tarnowski, C.; Morris, M.; Long, M.W. Three-dimensional cellular development is essential for ex vivo formation of human bone. Nat. Biotechnol. 2000, 18, 954-958.
16. Petite, H.; Viateau, V.; Bensaid, W.; Meunier, A.; de Pollak, C.; Bourguignon, M.; Oudina, K.; Sedel, L.; Guillemin, G. Tissue-engineered bone regeneration. Nat. Biotechnol. 2000, 18, 959-963.
17. Schliephake, H.; Tavassol, F.; Gelinsky, M.; Dard, M.; Sewing, A.; Pompe, W. Use of a mineralized collagen membrane to enhance repair of calvarial defects in rats. Clin. Oral Implants Res. 2004, 15, 112-118.
18. Hutmacher, D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21, 2529-2543.
19. Yoshimoto, H.; Shin, Y.M.; Terai, H.; Vacanti, J.P. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003, 24, 2077-2082.
20. Ma, Z.W.; Kotaki, M.; Inai, R.; Ramakrishna, S. Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng. 2005, 11, 101-109.
21. Sung, H.J.; Meredith, C.; Johnson, C.; Galis, Z.S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004, 25, 5735-5742.
22. Yang, Y.Y.; Chung, T.S.; Ng, N.P. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001, 22, 231-241.
23. Sahoo, S.; Cho-Hong, J.G.; Siew-Lok, T. Development of hybrid polymer scaffolds for potential applications in ligament and tendon tissue engineering. Biomed. Mater. 2007, 2, 169-173.
24. Yang, T.L.; Hsiao, Y.C.; Young, T.H. Comparison of plga, pcl, and chitosan in salivary gland branching morphogenesis. Biomed. Eng. Appl. Basis Commun. 2008, 20, 287-296.
25. Baker, S.C.; Rohman, G.; Southgate, J.; Cameron, N.R. The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering. Biomaterials 2009, 30, 1321-1328.
26. Saito, E.; Kang, H.; Taboas, J.M.; Diggs, A.; Flanagan, C.L.; Hollister, S.J. Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications. J. Mater. Sci.: Mater. Med. 2010, 21, 2371-2383.
27. Caplan, A.I. The mesengenic process. Clin. Plast. Surg. 1994, 21, 429-435.
28. Filshie, R.J.A.; Zannettino, A.C.W.; Makrynikola, V.; Gronthos, S.; Henniker, A.J.; Bendall, L.J.; Gottlieb, D.J.; Simmons, P.J.; Bradstock, K.F. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies. Leukemia 1998, 12, 414-421.
29. Gronthos, S.; Fitter, S.; Diamond, P.; Simmons, P.J.; Itescu, S.; Zannettin, A.C.W. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells Dev. 2007, 16, 953-963.
30. Gronthos, S.; Graves, S.E.; Ohta, S.; Simmons, P.J. The Stro-1(+) Fraction of Adult Human Bone-Marrow Contains the Osteogenic Precursors. Blood 1994, 84, 4164-4173.
31. Gronthos, S.; Simmons, P.J. The growth-factor requirements of stro-1-positive human bone-marrow stromal precursors under serum-deprived conditions in-vitro. Blood 1995, 85, 929-940.
32. Gronthos, S.; Simmons, P.J.; Graves, S.E.; Robey, P.G. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 2001, 28, 174-181.
33. Gronthos, S.; Stewart, K.; Graves, S.E.; Hay, S.; Simmons, P.J. Integrin expression and function on human osteoblast-like cells. J. Bone Miner. Res. 1997, 12, 1189-1197.
34. Gronthos, S.; Zannettino, A.C.W.; Hay, S.J.; Shi, S.T.; Graves, S.E.; Kortesidis, A.; Simmons, P.J. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci. 2003, 116, 1827-1835.
35. Lundberg, P.; Allison, S.J.; Lee, N.J.; Baldock, P.A.; Brouard, N.; Rost, S.; Enriquez, R.F.; Sainsbury, A.; Lamghari, M.; Simmons, P.; Eisman, J.A.; Gardiner, E.M.; Herzog, H. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J. Biol. Chem. 2007, 282, 19082-19091.
36. Semerad, C.L.; Christopher, M.J.; Liu, F.L.; Short, B.; Simmons, P.J.; Winkler, I.; Levesque, J.P.; Chappel, J.; Ross, F.P.; Link, D.C. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005, 106, 3020-3027.
37. Simmons, P.J.; Torok-Storb, B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991, 78, 55-62.
38. Bianco, P.; Robey, P.G.; Simmons, P.J. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008, 2, 313-319.
39. Caplan, A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9, 641-650.
40. Friedenstein, A.J.; Gorskaja, J.F.; Kulagina, N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4, 267-274.
41. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
42. Deng, Z.L.; Sharff, K.A.; Tang, N.; Song, W.X.; Luo, J.Y.; Luo, X.J.; Chen, J.; Bennett, E.; Reid, R.; Manning, D.; Xue, A.; Montag, A.G.; Luu, H.H.; Haydon, R.C.; He, T.C. Regulation of osteogenic differentiation during skeletal development. Front. Biosci. 2008, 13, 2001-2021.
43. Colnot, C.; et al. Mechanisms of action of demineralized bone matrix in the repair of cortical bone defects. Clin. Orthop. Relat. Res. 2005, 435, 69-78.
44. Cremer, T.; Thielemann, F.W. Role of vessels and perivascular tissue in matrix induced osteogenesis. J. Dent. Res. 1986, 65, 543-543.
45. Schmid, J.; Wallkamm, B.; Hammerle, C.H.F.; Gogolewski, S.; Lang, N.P. The significance of angiogenesis in guided bone regeneration-A case report of a rabbit experiment. Clin. Oral Implants Res. 1997, 8, 244-248.
46. Huang, Q.; Wang, Y.D.; Wu, T.; Jiang, S.; Hu, Y.L.; Pei, G.X. Preliminary separation of the growth factors in platelet-rich plasma: Effects on the proliferation of human marrow-derived mesenchymal stem cells. Chin. Med. J. (Engl.) 2009, 122, 83-87.
47. Kasten, P.; Vogel, J.; Geiger, F.; Niemeyer, P.; Luginbuhl, R.; Szalay, K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 2008, 29, 3983-3992.
48. Hu, Z.; Peel, S.A.; Ho, S.K.; Sandor, G.K.; Clokie, C.M. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009, 107, 43-48.
49. van den Dolder, J.; Mooren, R.; Vloon, A.P.; Stoelinga, P.J.; Jansen, J.A. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng. 2006, 12, 3067-3073.
50. Ponte, A.L.; Marais, E.; Gallay, N.; Langonne, A.; Delorme, B.; Herault, O.; Charbord, P.; Domenech, J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25, 1737-1745.
51. Ji, J.F.; He, B.P.; Dheen, S.T.; Tay, S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22, 415-427.
52. Chamberlain, G.; Wright, K.; Rot, A.; Ashton, B.; Middleton, J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: Comparison with human. PLoS One 2008, 3, e2934.
53. Wang, J.F.; Park, I.W.; Groopman, J.E. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C. Blood 2000, 95, 2505-2513.
54. Hall, M.P.; Band, P.A.; Meislin, R.J.; Jazrawi, L.M.; Cardone, D.A. Platelet-rich plasma: Current concepts and application in sports medicine. J. Am. Acad. Orthop. Surg. 2009, 17, 602-608.
55. Kim, E.S.; Kim, J.J.; Park, E.J. Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material. J. Adv. Prosthodont. 2010, 2, 7-13.
56. Yoshimi, R.; Yamada, Y.; Ito, K.; Nakamura, S.; Abe, A.; Nagasaka, T.; Okabe, K.; Kohgo, T.; Baba, S.; Ueda, M. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering. J. Craniofac. Surg. 2009, 20, 1523-1530.
57. Sarkar, M.R.; Augat, P.; Shefelbine, S.J.; Schorlemmer, S.; Huber-Lang, M.; Claes, L.; Kinzl, L.; Ignatius, A. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 2006, 27, 1817-1823.
58. Simsek, S.B.; Keles, G.C.; Baris, S.; Cetinkaya, B.O. Comparison of mesenchymal stem cells and autogenous cortical bone graft in the treatment of class II furcation defects in dogs. Clin. Oral Investig. 2010, doi: 10.1007/s00784-010-0486-7.
59. Schuckert, K.H.; Jopp, S.; Osadnik, M. Modern bone regeneration instead of bone transplantation: A combination of recombinant human bone morphogenetic protein-2 and platelet-rich plasma for the vertical augmentation of the maxillary bone-a single case report. Tissue Eng. Part C Methods 2010, 16, 1335-1346.
60. Stendahl, J.C.; Rao, M.S.; Guler, M.O.; Stupp, S.I. Intermolecular forces in the self-assembly of peptide amphiphilic nanofibers. Adv. Funct. Mater. 2006, 16, 499-508.
61. Behanna, H.A.; Donners, J.J.; Gordon, A.C.; Stupp, S.I. Coassembly of amphiphiles with opposite peptide polarities into nanofibers. J. Am. Chem. Soc. 2005, 127, 1193-2000.
62. Claussen, R.C.; Rabatic, B.M.; Stupp, S.I. Aqueous self-assembly of unsymmetric peptide amphiphiles into nanofibers with hydrophilic cores and surfaces. J. Am. Chem. Soc. 2003, 125, 12680-12681.
63. Hartgerink, J.D.; Beniash, E.; Stupp, S.I. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 2001, 294, 1684-1688.
64. Hartgerink, J.D.; Beniash, E.; Stupp, S.I. Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials. Proc. Natl. Acad. Sci. USA 2002, 99, 5133-5138.
65. Kapadia, M.R.; Chow, L.W.; Tsihlis, N.D.; Ahanchi, S.S.; Hrabie, J.A.; Murar, J.; Martinez, J.; Popowich, D.A.; Jiang, Q.; Hrabie, J.A.; Saavedra, J.E.; Keefer, L.K.; HUlvat, J.F.; Stupp, S.I.; Kibbe, M.P. Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia. J. Vasc.Surg. 2008, 47, 173-182.
66. Rajangam, K.; Behanna, H.A.; Hui, M.J.; Han, X.; Hulvat, J.F.; Lomasney, J.W.; Stupp, S.I. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett. 2006, 6, 2086-2090.
67. Sargeant, T.D.; Guler, M.O.; Oppenheimer, S.M.; Mata, A.; Satcher, R.L.; Dunand, D.C.; Stupp, S.I. Hybrid bone implants: Self-assembly of peptide amphiphile nanofibers within porous titanium. Biomaterials 2008, 29, 161-171.
68. Silva, G.A.; Czeisler, C.; Niece, K.L.; Beniash, E.; Harrington, D.A.; Kessler, J.A.; Stupp, S.I. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 2004, 303, 1352-1355.
69. Tysseling-Mattiace, V.M.; Sahni, V.; Niece, K.L.; Birch, D.; Czeisler, C.; Fehlings, M.G.; Stupp, S.I.; Kessler, J.A. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury. J. Neurosci. 2008, 28, 3814-3823.
70. Behanna, H.A.; Donners, J.J.J.M.; Gordon, A.C.; Stupp, S.I. Coassembly of amphiphiles with opposite peptide polarities into nanofibers. J. Am. Chem. Soc. 2005, 127, 1193-1200.
71. Bull, S.R.; Guler, M.O.; Bras, R.E.; Meade, T.J.; Stupp, S.I. Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett. 2005, 5, 1-4.
72. Niece, K.L.; Hartgerink, J.D.; Donners, J.J.; Stupp, S.I. Self-assembly combining two bioactive peptide-amphiphile molecules into nanofibers by electrostatic attraction. J. Am. Chem. Soc. 2003, 125, 7146-7147.
73. Guler, M.O.; Soukasene, S.; Hulvat, J.F.; Stupp, S.I. Presentation and recognition of biotin on nanofibers formed by branched peptide amphiphiles. Nano Lett. 2005, 5, 249-252.
74. Sargeant, T.D.; Guler, M.O.; Oppenheimer, S.M.; Mata, A.; Satcher, R.L.; Dunand, D.C.; Stupp, S.I. Hybrid bone implants: Self-assembly of peptide amphiphile nanofibers within porous titanium. Biomaterials 2008, 29, 161-171.
75. Sone, E.D.; Stupp, S.I. Semiconductor-encapsulated peptide-amphiphile nanofibers. J. Am. Chem. Soc. 2004, 126, 12756-12757.
76. Ali, S.A.M.; Doherty, P.J.; Williams, D.F. The mechanisms of oxidative-degradation of biomedical polymers by free-radicals. J. Appl. Polym. Sci. 1994, 51, 1389-1398.
77. Hsu, L.; Cvetanovich, G.L.; Stupp, S.I. Peptide amphiphile nanofibers with conjugated polydiacetylene backbones in their core. J. Am. Chem. Soc. 2008, 130, 3892-3899.
78. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
79. Ferrari, M. Nanogeometry: Beyond drug delivery. Nat. Nanotechnol. 2008, 3, 131-132.
80. Tasciotti, E.; Liu, X.; Bhavane, R.; Plant, K.; Leonard, A.D.; Price, B.K.; Cheng, M.M.; Decuzzi, P.; Tour, J.M.; Robertson, F.; Ferrari, M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat.Nanotechnol. 2008, 3, 151-157.
81. Canham, L.T. Bioactive silicon structure fabrication through nanoetching techniques. Adv. Mater. 1995, 7, 1033-1037.
82. Canham, L.T.; Newey, J.P.; Reeves, C.L.; Houlton, M.R.; Loni, A.; Simons, A.J.; Cox, T.I. The Effects of DC electric currents on the in-vitro calcification of bioactive silicon wafers. Adv. Mater. 1996, 8, 847-849.
83. Canham, L.T.; Reeves, C.L.; Newey, J.P.; Houlton, M.R.; Cox, T.I.; Buriak, J.M.; Stewart, M.P. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma. Adv. Mater.1999, 11, 1505-1507.
84. Sun, W.; Puzas, J.E.; Sheu, T.J.; Fauchet, P.M. Porous silicon as a cell interface for bone tissue engineering. Phys. Status Solidi A 2007, 204, 1429-1433.
85. Low, S.P.; Williams, K.A.; Canham, L.T.; Voelcker, N.H. Evaluation of mammalian cell adhesion on surface-modified porous silicon. Biomaterials 2006, 27, 4538-4546.
86. Gao, T.; Aro, H.T.; Ylanen, H.; Vuorio, E. Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials 2001, 22, 1475-1483.
87. Ducheyne, P.; Qiu, Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999, 20, 2287-2303.
88. Amato, F.; Cosentino, C.; Pricl, S.; Ferrone, M.; Fermeglia, M.; Cheng, M.M.C.; Walczak, R.; Ferrari, M. Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model. Biomed. Microdevices 2006, 8, 291-298.
89. Chu, T.M.; Warden, S.J.; Turner, C.H.; Stewart, R.L. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. Biomaterials 2007, 28, 459-467.
90. Zhang, M.Q.; Desai, T.; Ferrari, M. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials 1998, 19, 953-960.
91. Yamada, Y.; Ueda, M.; Naiki, T.; Takahashi, M.; Hata, K.; Nagasaka, T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: Tissue-engineered bone regeneration. Tissue Eng. 2004, 10, 955-964.
92. Dallari, D.; Fini, M.; Stagni, C.; Torricelli, P.; Aldini, N.N.; Giavaresi, G.; Cenni, E.; Baldini, N.; Cenacchi, A.; Bassi, A.; Giardino, R.; Fornasari, P.M.; Giunti, A. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J. Orthop. Res. 2006, 24, 877-888.
93. Thorwarth, M.; Wehrhan, F.; Schultze-Mosgau, S.; Wiltfang, J.; Schlegel, K.A. PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation. Bone 2006, 38, 30-40.
94. Yamamoto, M.; Takahashi, Y.; Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24, 4375-4383.
95. Liu, Y.; de Groot, K.; Hunziker, E.B. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005, 36, 745-757.
96. Kim, C.S.; Kim, J.I.; Kim, J.; Choi, S.H.; Chai, J.K.; Kim, C.K.; Cho, K.S. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 2005, 26, 2501-1507.
97. Kasten, P.; Vogel, J.; Luginbuhl, R.; Niemeyer, P.; Weiss, S.; Schneider, S.; Kramer, M.; Leo, A.; Richter, W. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics. Cells Tissues Organs 2006, 183, 68-79.
98. Asou, Y.; Rittling, S.R.; Yoshitake, H.; Tsuji, K.; Shinomiya, K.; Nifuji, A.; Denhardt, D.T.; Noda, M. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 2001, 142, 1325-1332.
99. Yaffe, A.; Kollerman, R.; Bahar, H.; Binderman, I. The influence of alendronate on bone formation and resorption in a rat ectopic bone development model. J. Periodontol. 2003, 74, 44-50.
100. Yuan, H.; van Blitterswijk, C.A.; de Groot, K.; de Bruijn, J.D. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds. Tissue Eng. 2006, 12, 1607-1615.
101. Bruder, S.P.; Fox, B.S. Tissue engineering of bone. Cell based strategies. Clin. Orthop. Relat. Res. 1999, 367, S68-S83.
102. Kneser, U.; Schaefer, D.J.; Polykandriotis, E.; Horch, R.E. Tissue engineering of bone: The reconstructive surgeon's point of view. J. Cell. Mol. Med. 2006, 10, 7-19.
103. Mistry, A.S.; Mikos, A.G. Tissue engineering strategies for bone regeneration. Adv. Biochem. Eng. Biotechnol. 2005, 94, 1-22.